Showing results (301-310 of 329) with videos related to
Sort By:
Pageof 33
Nature|June 23, 2000
Redundant roles for the TFIID and SAGA complexes in global transcriptionT I Lee, H C Causton, F C Holstege, et al.The New England Journal of Medicine|November 19, 1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVDG P Canellos, J R Anderson, K J Propert, et al.Cancer|June 1, 1997
Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group BN J Yogelzang, J E Herndon, C Cirrincione, et al.The New England Journal of Medicine|October 4, 1990
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancerR O Dillman, S L Seagren, K J Propert, et al.Blood|November 15, 1991
A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group BR O Dillman, R B Davis, M R Green, et al.Lung Cancer (Amsterdam, Netherlands)|December 19, 1998
Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: a Cancer and Leukemia Group B studyS L Graziano, J A Kern, J E Herndon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II studyG M Strauss, J E Herndon, D D Sherman, et al.American Journal of Clinical Oncology|June 1, 1984
The treatment of melanoma with m-AMSA. A Cancer and Leukemia Group B phase II studyP C Amrein, R F Poulin, M Coleman, et al.Cancer|June 1, 1996
Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935P Kumar, J Herndon, M Langer, et al.Archives of Disease in Childhood|February 1, 1994
Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal periodL T Weaver, M R Green, K Nicholson, et al.Pageof 33